These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1129346)

  • 1. Discriminative stimulus properties of mescaline: mescaline or metabolite?
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(1):109-14. PubMed ID: 1129346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonin in the discriminative stimulus properties of mescaline.
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(3):429-35. PubMed ID: 125425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study with mescaline-8-C14 in mice: effect of amine oxidase inhibitors on metabolism.
    Shah NS; Himwich HE
    Neuropharmacology; 1971 Sep; 10(5):547-56. PubMed ID: 5126692
    [No Abstract]   [Full Text] [Related]  

  • 4. Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat.
    Bridger WH; Mandel IJ
    Biol Psychiatry; 1971; 3(4):379-85. PubMed ID: 5163821
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of aminoacetonitrile, an amine oxidase inhibitor, on mescaline metabolism in the rabbit.
    Riceberg LJ; Simon M; Van Vunakis H; Abeles RH
    Biochem Pharmacol; 1975 Jan; 24(1):119-25. PubMed ID: 1168468
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.
    Browne RG; Harris RT; Ho BT
    Psychopharmacologia; 1974; 39(1):43-56. PubMed ID: 4425137
    [No Abstract]   [Full Text] [Related]  

  • 7. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic effect of disulfiram evaluated in an animal model.
    Bhadra S; Prather PL; Elkhayat I; Benjamin D; Harris CM; Lal H
    J Stud Alcohol; 1993 Jan; 54(1):5-10. PubMed ID: 8394957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB; Callahan PM
    Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat.
    Commissaris RL; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):601-3. PubMed ID: 7433492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 14C-mescaline by rabbit lung.
    Roth RA; Roth JA; Gillis CN
    J Pharmacol Exp Ther; 1977 Feb; 200(2):394-401. PubMed ID: 839444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline.
    Smythies JR; Johnston VS; Bradley RJ
    Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of the stimulus properties of mescaline by a serotonin antagonist.
    Winter JC
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):250-3. PubMed ID: 1156033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of a chronic administration of mescaline in dynamic behavioural situations.
    Fundaro' A; Molinengo L; Cassone MC; Orsetti M
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):41-8. PubMed ID: 3704173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.